Subconjuctival application of 5-fluorouracil (5-FU) following surgical treatment of glaucoma with deep sclerectomy - Indications, complications and initial evaluation of efficacy;Podspojówkowe zastosowanie 5-fluorouracylu po leczeniu operacyjnym jaskry metoda̧ sklerektomii głȩbokiej - Wskazania, powikłania, wstȩpna ocena skuteczności

Klinika Oczna

Volumn 107, Issue 4-6, 2005, Pages 232-235

  Wojtulewicz, Małgorzata ^a,b   Rȩkas, Marek ^a   Wierzbowska, Joanna ^a  

^a Instytutu Medycznego W Warszawie   (Poland)

^b Wojskowego Instytutu Medycznego   (Poland)

Author keywords

5 fluorouracil; Deep sclerectomy; Filtering bleb dysfunction; Glaucoma

Indexed keywords

FLUOROURACIL; ANTIMETABOLITE;

ARTICLE; ASTIGMATISM; CELL PROLIFERATION; CHOROID DETACHMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; FIBROBLAST; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; KERATOPATHY; POSTOPERATIVE PERIOD; SCLERECTOMY; TREATMENT INDICATION; VASODILATATION; ADJUVANT CHEMOTHERAPY; AGED; FEMALE; INJECTION; MALE; MIDDLE AGED; SCLERA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES; CHEMOTHERAPY, ADJUVANT; FEMALE; FLUOROURACIL; GLAUCOMA; HUMANS; INJECTIONS; MALE; MIDDLE AGED; SCLERA; TREATMENT OUTCOME;

EID: 27244450180     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Fyodorow S. N.: Non-penetrating deep sclerectomy in open angle glaucoma. Eye Microsurg., 1990, 44-46.
2. Mora J. S., Nguyen N., Iwach A. G., Gaffney M. M., Hetherington J. Jr., Hoskins H. D. Jr., Wong P. C., Tran H., Dickens Ch. J.: Trabeculectomy with intraoperative sponge 5-fluorouracil. Ophthalmology, 1996, 103, 963-970.
3. Chang S. H., Hou C. H.: Needling revision with subconjunctival 5-fluorouracil in failing filtering blebs. Chang Gung Med. J., 2002, 25, 97-103.
4. Durak I., Ozbek Z., Yaman A., Soyler M., Cingil G.: The role of needle revision and 5-fluorouracil application over the filtration site in the management of bleb failure after trabeculectomy; a prospective study. Doc. Ophthalmol., 2003, 106, 189-193.
5. Lewandowska-Furmanik M., Toczołowski J.: Zastosowanie 5-fluorouracylu we wczesnym okresie po trabekulektomii. Klin. Oczna, 1996, 98, 427-428.
6. Stilma J. S.: Trabeculectomy with 5-fluorouracil in complicated glaucoma. Klin. Oczna, 1993, 95, 81-83.
7. Zaczek A.: 5-fluorouracyl w chirurgii jaskry. Klin. Oczna, 1994, 96, 329-331.
8. Chaundhry I. A., Pasha M. A., O'Connor D. J., Weitzman M. L., Caprioli J.: Randomized, controlled study of low-dose 5-fluorouracil in primary trabeculectomy. Am. J. Ophthalmol., 2000, 130, 700-703.
9. WuDunn D., Cantor L. B., Palanca-Capistrano A. M., Hoop J., Alvi N. P., Finley C., Lakhani V., Burnstein A., Knotts S. L.: A prospective randomized trial comparing intraoperative 5-fluorouracil vs mitomycin C in primary trabeculectomy. Am. J. Ophthalmol., 2002, 134, 521-528.
10. Dreyer E. B., Chaturvedi N., Zurakowski D.: Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment. Arch. Ophthalmol., 1995, 113, 578-580.
11. Mielke C., Dawka V. K., Anand N.: Intraoperative 5-fluorouracil application during primary trabeculectomy in Nigeria; a comparative study. Eye, 2003, 17, 829-834.
12. Singh K., Egbert P. R., Byrd S., Budenz D. L., Williams A. S., Decker J. H., Dadzie P.: Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am. J. Ophthalmol., 1997, 123, 48-53.
13. Szaflik J., Zalewska-Żmijewska A.: Farmakologiczne metody zwiȩkszania efektywności zabiegów przetokowych. Klin. Oczna, 2004, 106, 273-278.
14. Akarsu C., Onol M., Hasanreisoglu B.: Postoperative 5-fluorouracil versus intraoperative mitomycin C in high-risk glaucoma filtering surgery: extended follow up. Clin. Exp. Ophthalmol., 2003, 31, 199-205.
15. Anonymous: Five-year follow-up of the Fluorouracil Filtering Surgery Study. The Fluorouracil Filtering Surgery Study Group. Am. J. Ophthalmol., 1996, 121, 349-366.
16. Singh R. P., Goldberg I., Mohsin M.: The efficacy and safety of intraoperative and/or postoperative 5-fluorouracil in trabeculectomy and phacotrabeculectomy. Clin. Exp. Ophthalmol., 2001, 29, 296-302.